News
DGAP-News: Eckert & Ziegler Partners with University Health Network and CanProbe to Advance PENTIXAFOR Imaging Diagnostic Tool for Wider Application
DGAP-News: Eckert & Ziegler Partners with University Health Network and CanProbe to Advance PENTIXAFOR Imaging Diagnostic Tool for Wider Application
DGAP-News: Eckert & Ziegler kooperiert mit University Health Network und CanProbe zur Anwendungserweiterung des Radiodiagnostikums PENTIXAFOR
DGAP-News: Eckert & Ziegler kooperiert mit University Health Network und CanProbe zur Anwendungserweiterung des Radiodiagnostikums PENTIXAFOR
3 Oversold Stocks with Big RSI Rebound Potential
Everybody loves finding a bargain or getting a good deal, and it's no different when it comes to stocks. One of the most popular technical indicators for helping investors find these is the
Here’s Why Surgery Partners Could Be the Next Hot Takeover
With the stock markets trading near highs again and the start of a lower interest rates cycle, the backdrop for mergers, spin-offs, and acquisitions continues to improve. Elevated stock prices are
Here’s Why Surgery Partners Could Be the Next Hot Takeover
With the stock markets trading near highs again and the start of a lower interest rates cycle, the backdrop for mergers, spin-offs, and acquisitions continues to improve. Elevated stock prices are
Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs. The company has a vast portfolio of
Top Stress-Free Stock Picks to Secure Your Portfolio This Fall
Investors often think of the start of autumn as a time of increased volatility for the market due to a phenomenon known as the "September Effect," a historically-verifiable trend in which the
Top Stress-Free Stock Picks to Secure Your Portfolio This Fall
Investors often think of the start of autumn as a time of increased volatility for the market due to a phenomenon known as the "September Effect," a historically-verifiable trend in which the
New Book Reveals First Ever Neuroscience-Powered GenAI Tools Global Brands Are Using to Win Consumers
Written by Sensori.Ai CEO Dr. A.K. Pradeep, “Neuro AI: How to Win the Minds of Consumers Using Neuroscience-Powered Gen AI” leverages his success working with the biggest global brands to
Neues Buch enthüllt erstmals neurowissenschaftlich gestützte GenAI-Tools, die internationale Marken zur Kundengewinnung einsetzen
In seinem Buch „Neuro AI: How to Win the Minds of Consumers Using Neuroscience-Powered Gen AI“ teilt Sensori.Ai-CEO Dr. A.K. Pradeep die Erkenntnisse aus seiner erfolgreichen Zusammenarbeit
Medtronic Stock: Growth On Rise of the Cardiovascular Machines
Medtronic plc (NYSE: MDT) is a leading global medical device maker in the medical sector. Its innovative and critical medical device portfolio addresses chronic diseases an aging population
Agilent Technologies Thrives From the Forever Chemicals Crackdown
Agilent Technologies Inc. (NYSE: A) is a diversified global leader in the life sciences, diagnostics, and applied chemical markets. The company provides equipment systems, instruments, software
3 Stocks to Own if You Are Bearish on The Market
There are many reasons for the market to be bearish today, but the primary ones are the FOMC and the outlook for interest rates. The FOMC is set to cut rates this year, but the economic data isn’t
3 Stocks to Own if You Are Bearish on The Market
There are many reasons for the market to be bearish today, but the primary ones are the FOMC and the outlook for interest rates. The FOMC is set to cut rates this year, but the economic data isn’t
Diabetes and Neuro Products Ignite Medtronic’s Q1 Earnings Rally
Shares of medical device manufacturer Medtronic PLC (NYSE: MDT) are down about 35% from their highs of roughly three years ago, but promising results from the company's first quarter of fiscal
MicroVision meldet die Ergebnisse des zweiten Quartals 2024
REDMOND, WA / ACCESSWIRE / 7. August 2024 / MicroVision, Inc. (NASDAQ:MVIS), ein führender Anbieter von MEMS-basierten Festkörper-Automobil-LiDAR- und modernen Fahrerassistenzlösungen (ADAS),
MicroVision Announces Second Quarter 2024 Results
REDMOND, WA / ACCESSWIRE / August 7, 2024 / MicroVision, Inc. (NASDAQ:MVIS), a leader in MEMS-based solid-state automotive lidar and ADAS solutions, today announced its second quarter 2024
Medical Technology Stock Benefits from Rising Acute Care Demand
Medical and surgical products manufacturer Stryker Co. (NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry. Acute care is considered short-term intensive
Humana Slides on Profitability Concerns Despite Q2 Earnings Beat
Humana Inc. (NYSE: HUM) is a leading health insurer predominantly focused on Medicare Advantage plans, serving millions of individuals and families nationwide. The company's business model centers
Is This Telehealth Stock a Buy After the Recent Pullback?
Hims & Hers Health, Inc. (NYSE: HIMS) is a prominent player in the telehealth sector, which is part of the larger healthcare sector. The company has garnered significant attention from
Is This Telehealth Stock a Buy After the Recent Pullback?
Hims & Hers Health, Inc. (NYSE: HIMS) is a prominent player in the telehealth sector, which is part of the larger healthcare sector. The company has garnered significant attention from
Why This Healthcare Stock is a Strong Buy Despite Headwinds
UnitedHealth Group (NYSE: UNH) has headwinds, but its healthcare business and operational quality offset them, setting the stock to hit new all-time highs. The primary culprit is the recent
Why This Healthcare Stock is a Strong Buy Despite Headwinds
UnitedHealth Group (NYSE: UNH) has headwinds, but its healthcare business and operational quality offset them, setting the stock to hit new all-time highs. The primary culprit is the recent